Scarica l'app Stockscreener
0.00
100.00%
-0.0973
Dopo l'orario di chiusura:
.10
0.10
+
Precedente Chiudi:
$0.0973
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$95.35M
Reddito:
$25.19M
Utile/perdita netta:
$-34.53M
Rapporto P/E:
0.00
EPS:
-0.036
Flusso di cassa netto:
$-20.62M
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.00
$0.00
Portata 52W:
$0.00
$0.1952
Zomedica Corp Stock (ZOM) Company Profile
Nome
Zomedica Corp
Settore
Telefono
734-369-2555
Indirizzo
100 Phoenix Drive, Suite 190, Ann Arbor, MI
Confronta ZOM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZOM
Zomedica Corp
|
0.00 | 95.35M | 25.19M | -34.53M | -20.62M | -0.036 |
|
ZTS
Zoetis Inc
|
150.91 | 65.46B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.18 | 46.11B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.23 | 45.84B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
14.29 | 16.37B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
293.46 | 12.81B | 2.76B | 1.11B | 898.10M | 22.77 |
Zomedica Corp Stock (ZOM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-01-06 | Iniziato | Dawson James | Buy |
Zomedica Corp Borsa (ZOM) Ultime notizie
Press Release Distribution & PR Platform - ACCESS Newswire
Zomedica Introduces Enhanced Audio Features for the VETGuardian(R) Zero-touch Vital Signs Remote Monitoring System - ACCESS Newswire
Leading Proxy Advisory Firm ISS Recommends Zomedica Shareholders Vote "FOR" Proposed Reverse Stock Split - ACCESS Newswire
Zomedica Corp. (ZOMDF): Among Stocks Insiders Were Buying In Q1 2025 - Yahoo Finance
20 Stocks Insiders Were Buying In Q1 2025 - Insider Monkey
Is Zomedica Corp. (ZOMDF) the Cheapest Stock Insiders Are Buying In March? - Insider Monkey
15 Cheapest Stocks Insiders Are Buying In March - Insider Monkey
Zscaler, Rocket Lab, American Tower, Intuit, and Zomedica: Insider Moves Unveiled! - TipRanks
Zomedica director Rodney Williams acquires $6,900 in stock By Investing.com - Investing.com Canada
Zomedica director Rodney Williams acquires $6,900 in stock - Investing.com
Zomedica’s CFO Jordan Scott acquires $18,600 in common stock By Investing.com - Investing.com Canada
Zomedica director Christopher MacLeod buys $8,437 in stock - Investing.com India
Zomedica’s CFO Jordan Scott acquires $18,600 in common stock - Investing.com
Zomedica director Christopher MacLeod buys $8,437 in stock By Investing.com - Investing.com Australia
Zomedica CEO Larry Heaton acquires $29,702 in common stock By Investing.com - Investing.com Canada
Zomedica senior vice president buys $48,998 in common stock By Investing.com - Investing.com India
Zomedica director Johnny Powers acquires $33,650 in common stock By Investing.com - Investing.com Australia
Zomedica director Williams acquires $6,900 in common stock By Investing.com - Investing.com Canada
Zomedica director Christopher MacLeod acquires $8,437 in stock - Investing.com India
Zomedica COO Blair Anthony K acquires $30,000 in common stock By Investing.com - Investing.com Australia
Zomedica director Christopher MacLeod acquires $8,437 in stock By Investing.com - Investing.com South Africa
Zomedica director Jeffrey Rowe buys $96,098 in stock By Investing.com - Investing.com South Africa
Zomedica director Johnny Powers acquires $33,650 in common stock - Investing.com
Zomedica COO Blair Anthony K acquires $30,000 in common stock - Investing.com
Zomedica CEO Larry Heaton acquires $29,702 in common stock - Investing.com
Zomedica director Jeffrey Rowe buys $96,098 in stock - Investing.com
Zomedica senior vice president buys $48,998 in common stock - Investing.com
Zomedica director Williams acquires $6,900 in common stock - Investing.com
Zomedica Reports Record Revenue and Strong Growth - TipRanks
Earnings call transcript: Zomedica Q4 2024 shows revenue growth - Investing.com India
Zomedica Reports Record Revenue of $7.9 Million for the Fourth Quarter and $27.3 Million for the Full Year 2024; 70% Gross Margin, and $71 Million in Liquidity to Support Growth - ACCESS Newswire
Zomedica (ZOM) Expected to Announce Quarterly Earnings on Thursday - Defense World
Zomedica Transitions to OTCQB Market Following NYSE Delisting - TipRanks
Zomedica Corp. Announces Transition to OTCQB Venture Market - Herald Palladium
About Us - Financial Content
Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone - ACCESS Newswire
Zomedica Interview To Air on Bloomberg U.S. on the RedChip Money Report(R) - ACCESS Newswire
Zomedica Corp Azioni (ZOM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.57%
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):